The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo

Journal of Applied Microbiology

Volumn 117, Issue 3, 2014, Pages 834-845

  Kim, S H ^a   Huh, C S ^b,c   Choi, I D ^a   Jeong, J W ^a   Ku, H K ^a   Ra, J H ^a   Kim, T Y ^a   Kim, G B ^d   Sim, J H ^a   Ahn, Y T ^a  

^a Korea Yakult Co   (South Korea)

^b Plant Genomics and Breeding Institute and Research Institute for Agriculture and Life Sciences   (South Korea)

^c Seoul National University   (South Korea)

^d Chung Ang University   (South Korea)

Author keywords

AKT; Glucose uptake; GLUT4; Insulin resistance; IRS 1; Rat L6 skeletal muscle cells; TNF

Indexed keywords

CELL SIGNALING; CYTOLOGY; GENES; GLUCOSE; INSULIN; METABOLISM; MUSCLE;

AKT; BIFIDOBACTERIUM LACTIS; GLUCOSE UPTAKE; GLUT4; INSULIN RESISTANCE; IRS-1; RAT L6 SKELETAL MUSCLE CELL; SKELETAL MUSCLE CELLS; TUMOR NECROSE FACTOR-Α; TUMOR NECROSIS FACTORS;

RATS;

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CHOLESTEROL; GLUCOSE; GLUCOSE TRANSPORTER 4; HY 8101; INSULIN; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROBIOTIC AGENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; GLYCOGEN; INSULIN RECEPTOR SUBSTRATE;

BACTERIUM; BIOLOGICAL UPTAKE; CELL ORGANELLE; DIABETES; GLUCOSE; NUMERICAL MODEL; ORGANIC COMPOUND; RODENT; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; DNA SEQUENCE; DOWN REGULATION; DRUG EFFECT; FOOD INTAKE; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; GLYCOGEN MUSCLE LEVEL; GLYCOGEN SYNTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID METABOLISM; MALE; MOUSE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WESTERN BLOTTING; ANALYSIS; ANIMAL; BIFIDOBACTERIUM; BLOOD; C57BL MOUSE; CELL LINE; DIABETES MELLITUS, TYPE 2; LIVER; METABOLISM; SKELETAL MUSCLE;

BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; MUS; RATTUS;

ANIMALS; BIFIDOBACTERIUM; BLOOD GLUCOSE; CELL LINE; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PROBIOTICS; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85027951428     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.12573     Document Type: Article

References (38)

1. Bleau, C., Lamontague, L. and Savavard, R. (2004) New Lactobacillus acidophilus isolates reduce the release of leptin by murine adipocytes leading to lower interferon-gamma production. Clin Exp Immunol 104, 427-435.
2. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F. et al. (2007a) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772.
3. Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., Gibson, G.R. and Delzenne, N.M. (2007b) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374-2383.
4. Chen, X., McMahon, E.G. and Gulve, E.A. (1998) Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1. Am J Physiol Endocrinol Metab 275, 272-277.
5. DeFronzo, R.A., Jacot, E., Jequier, E., Maeder, E., Wahren, J. and Felber, J.P. (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30, 1000-1007.
6. DeFronzo, R.A., Bonadonna, R.C. and Ferrannini, E. (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15, 318-368.
7. Dohm, G.L., Tapscott, E.B., Pories, W.J., Dabbs, D.J., Flickinger, E.G., Meelheim, D., Fushiki, T., Atkinson, S.M. et al. (1988) An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest 82, 486-494.
8. Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G.G., Neyrinck, A.M., Possemiers, S., Van Holle, A. et al. (2011) Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60, 2775-2786.
9. Henriksen, E.J., Kinnick, T.R., Teachey, M.K., O'Keefe, M.P., Ring, D., Johnson, K.W. and Harrison, S.D. (2003) Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab 284, 892-900.
10. Hotamisligil, G.S., Shargill, N.S. and Spiegelman, B.M. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
11. Hotamisligil, G.S., Murray, D.L., Choy, L.N. and Spiegelman, B.M. (1994) Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91, 4854-4858.
12. Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F. and Spiegelman, B.M. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665-668.
13. Kintscher, U. and Law, R.E. (2005) PPARgamma-mediated insulin sensitization: the importance of fat versus muscle. Am J Physiol Endocrinol Metab 288, 287-291.
14. Klip, A. and Paquet, M.R. (1990) Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 13, 228-243.
15. Kootte, R.S., Vrieze, A., Holleman, F., Dallinga-Thie, G.M., Zoetendal, E.G., de Vos, W.M., Groen, A.K., Hoekstra, J.B. et al. (2012) The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 14, 112-120.
16. Makino, N., Maeda, T., Sugano, M., Satoh, S., Watanabe, R. and Abe, N. (2005) High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells. J Diabetes Complications 19, 347-355.
17. Makino, H., Kushiro, A., Ishikawa, E., Kubota, H., Gawad, A., Sakai, T., Oishi, K., Martin, R. et al. (2013) Mother-to-infant transmission of intestinal Bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS ONE 8, e78331.
18. Masahisa, K. (1984) Experimental Animal Models of Intractable Diseases. pp. 137-139. Tokyo: Soft Science.
19. Matsuzaki, T., Yamazaki, R., Hashimoto, S. and Yokokura, T. (1997) Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr J 44, 357-365.
20. Nikoulina, S.E., Ciaraldi, T.P., Mudaliar, S., Carter, L., Johnson, K. and Henry, R.R. (2002) Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51, 2190-2198.
21. Ohya, M., Taniguchi, A., Fukushima, M., Nakai, Y., Kawasaki, Y., Nagasaka, S., Kuroe, A., Taki, Y. et al. (2005) Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients. Metabolism 54, 1297-1301.
22. Orban, J.I. and Patterson, J.A. (2000) Modification of the phosphoketolase assay for rapid identification of bifidobacteria. J Microbiol Methods 40, 221-224.
23. Orena, S.J., Torchia, A.J. and Garofalo, R.S. (2000) Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes. J Biol Chem 275, 15765-15772.
24. Qi, C. and Pekala, P.H. (2000) Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. Proc Soc Exp Biol Med 223, 128-135.
25. Sekirov, I., Russell, S.L., Antunes, L.C. and Finlay, B.B. (2010) Gut microbiota in health and disease. Physiol Rev 90, 859-904.
26. Smith, A.G. and Muscat, G.E. (2005) Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Int J Biochem Cell Biol 37, 2047-2063.
27. Tabuchi, M., Ozaki, M., Tamura, A., Yamada, N., Ishida, T., Hosoda, M. and Hosono, A. (2003) Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 67, 1421-1424.
28. Tang, Y., Osawa, H., Onuma, H., Nishimiya, T., Ochi, M. and Makino, H. (1999) Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice. Diabetes 48, 1830-1835.
29. Thitaram, S.N., Siragusa, G.R. and Hinton, A. (2005) Bifidobacterium-selective isolation and enumeration from chicken caeca by a modified oligosaccharide antibiotic-selective agar medium. Lett Appl Microbiol 41, 355-360.
30. Vuong, T., Benhaddou-Andaloussi, A., Brault, A., Harbilas, D., Martineau, L.C., Vallerand, D., Ramassamy, C., Matar, C. et al. (2009) Antiobesity and antidiabetic effects of biotransformed blueberry juice in KKA(y) mice. Int J Obes (Lond) 33, 1166-1173.
31. Yadav, H., Jain, S. and Sinha, P.R. (2007) Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23, 62-68.
32. Yaffe, D. (1968) Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc Natl Acad Sci USA 61, 477-483.
33. Yamaguchi, K., Higashiura, K., Ura, N., Murakami, H., Hyakukoku, M., Furuhashi, M. and Shimamoto, K. (2003) The effect of tumor necrosis factor-alpha on tissue specificity and selectivity to insulin signaling. Hypertens Res 26, 389-396.
34. Yamamoto, N., Ueda, M., Kawabata, K., Sato, T., Kawasaki, K., Hashimoto, T. and Ashida, H. (2010) Artemisia princeps extract promoted glucose uptake in cultured L6 muscle cells via glucose transporter 4 translocation. Biosci Biotechnol Biochem 74, 2036-2042.
35. Yin, Y.N., Yu, Q.F., Fu, N., Liu, X.W. and Lu, F.G. (2010) Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol 16, 3394-3401.
36. Yun, S.I., Park, H.O., Lee, J.H. and Kang, J.H. (2009) Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 107, 1681-1686.
37. Zhang, Z., Zhao, M., Li, Q., Zhao, H., Wang, J. and Li, Y. (2009) Acetyl-l-carnitine inhibits TNF-alpha-induced insulin resistance via AMPK pathway in rat skeletal muscle cells. FEBS Lett 583, 470-474.
38. Zorzano, A., Palacín, M. and Gumà, A. (2005) Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle. Acta Physiol Scand 183, 43-58.